N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide

C68H85N11O8S — CID 164520134

IUPACN-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide
SMILESCc1ncsc1-c1ccc(CNC(=O)C2CC(O)CN2C(=O)[C@H](C(C)C)N2Cc3ccccc3C2=O)c(OCCCCCCCCCCC(=O)N2CCN(CCOc3cccc(N4C5CCC4CN(c4cc(-c6ccccc6O)nnc4N)C5)c3)CC2)c1
InChIInChI=1S/C68H85N11O8S/c1-45(2)63(78-40-49-17-11-12-20-55(49)67(78)84)68(85)77-43-53(80)37-59(77)66(83)70-39-48-25-24-47(64-46(3)71-44-88-64)35-61(48)87-33-15-9-7-5-4-6-8-10-23-62(82)75-30-28-74(29-31-75)32-34-86-54-19-16-18-50(36-54)79-51-26-27-52(79)42-76(41-51)58-38-57(72-73-65(58)69)56-21-13-14-22-60(56)81/h11-14,16-22,24-25,35-36,38,44-45,51-53,59,63,80-81H,4-10,15,23,26-34,37,39-43H2,1-3H3,(H2,69,73)(H,70,83)/t51?,52?,53?,59?,63-/m0/s1
InChIKeyXHHAPGBPKRUOBN-BCAGEFEQSA-N
MW1216.56 g/mol
LogP9.09
Rot. Bonds26

About N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide

N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide (PubChem CID 164520134) has the molecular formula C68H85N11O8S and a molecular weight of 1216.56 g/mol. Its IUPAC name is N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide.

Molecular Properties

Compound NameN-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide
PubChem CID164520134
Molecular FormulaC68H85N11O8S
Molecular Weight1216.56 g/mol
Exact Mass1215.63
IUPAC NameN-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide
SMILESCc1ncsc1-c1ccc(CNC(=O)C2CC(O)CN2C(=O)[C@H](C(C)C)N2Cc3ccccc3C2=O)c(OCCCCCCCCCCC(=O)N2CCN(CCOc3cccc(N4C5CCC4CN(c4cc(-c6ccccc6O)nnc4N)C5)c3)CC2)c1
InChIInChI=1S/C68H85N11O8S/c1-45(2)63(78-40-49-17-11-12-20-55(49)67(78)84)68(85)77-43-53(80)37-59(77)66(83)70-39-48-25-24-47(64-46(3)71-44-88-64)35-61(48)87-33-15-9-7-5-4-6-8-10-23-62(82)75-30-28-74(29-31-75)32-34-86-54-19-16-18-50(36-54)79-51-26-27-52(79)42-76(41-51)58-38-57(72-73-65(58)69)56-21-13-14-22-60(56)81/h11-14,16-22,24-25,35-36,38,44-45,51-53,59,63,80-81H,4-10,15,23,26-34,37,39-43H2,1-3H3,(H2,69,73)(H,70,83)/t51?,52?,53?,59?,63-/m0/s1
InChIKeyXHHAPGBPKRUOBN-BCAGEFEQSA-N
XLogP9.09
TPSA223.36 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds26
Heavy Atoms88
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001216.56
LogP ≤ 59.09
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide?
The IUPAC name of N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide (CID 164520134) is N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide.
What is the SMILES notation for N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide?
The canonical SMILES for N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide is Cc1ncsc1-c1ccc(CNC(=O)C2CC(O)CN2C(=O)[C@H](C(C)C)N2Cc3ccccc3C2=O)c(OCCCCCCCCCCC(=O)N2CCN(CCOc3cccc(N4C5CCC4CN(c4cc(-c6ccccc6O)nnc4N)C5)c3)CC2)c1.
What is the InChIKey of N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide?
The InChIKey is XHHAPGBPKRUOBN-BCAGEFEQSA-N. The full InChI is InChI=1S/C68H85N11O8S/c1-45(2)63(78-40-49-17-11-12-20-55(49)67(78)84)68(85)77-43-53(80)37-59(77)66(83)70-39-48-25-24-47(64-46(3)71-44-88-64)35-61(48)87-33-15-9-7-5-4-6-8-10-23-62(82)75-30-28-74(29-31-75)32-34-86-54-19-16-18-50(36-54)79-51-26-27-52(79)42-76(41-51)58-38-57(72-73-65(58)69)56-21-13-14-22-60(56)81/h11-14,16-22,24-25,35-36,38,44-45,51-53,59,63,80-81H,4-10,15,23,26-34,37,39-43H2,1-3H3,(H2,69,73)(H,70,83)/t51?,52?,53?,59?,63-/m0/s1.
What are the key properties of N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide?
N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide has a molecular weight of 1216.56 g/mol, XLogP of 9.09, 26 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[2-[11-[4-[2-[3-[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]phenoxy]ethyl]piperazin-1-yl]-11-oxoundecoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide is sourced from PubChem (CID 164520134), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).